Centiva Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-42
Closed -$11.6K 1642
2024
Q3
$11.6K Sell
42
-958
-96% -$249K ﹤0.01% 2049
2024
Q2
$243K Buy
+1,000
New +$158K 0.01% 1585
2023
Q4
Sell
-421
Closed -$74.6K 1759
2023
Q3
$74.6K Buy
+421
New +$80.3K ﹤0.01% 1561
2022
Q4
Sell
-456
Closed -$91K 1347
2022
Q3
$91K Buy
+456
New +$87K 0.01% 1297
2022
Q2
Sell
-2,594
Closed -$368K 1661
2022
Q1
$424K Buy
+2,594
New +$395K 0.02% 1050
2021
Q4
Sell
-1,731
Closed -$327K 1165
2021
Q3
$327K Sell
1,731
-2,945
-63% -$552K 0.03% 757
2021
Q2
$793K Buy
+4,676
New +$685K 0.06% 664
2021
Q1
Sell
-3,296
Closed -$428K 1133
2020
Q4
$428K Buy
3,296
+94
+3% +$12.6K 0.05% 509
2020
Q3
$466K Buy
3,202
+499
+18% +$70.9K 0.07% 368
2020
Q2
$400K Buy
2,703
+2,141
+381% +$289K 0.09% 342
2020
Q1
$61K Buy
562
+306
+120% +$35.3K 0.01% 534
2019
Q4
$29K Sell
256
-1,169
-82% -$117K 0.01% 778
2019
Q3
$115K Buy
+1,425
New +$113K 0.02% 546

Other funds holding ALNY